Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Sep;104(1):77–84. doi: 10.1111/j.1476-5381.1991.tb12388.x

Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.

A C Le Monnier de Gouville 1, I Cavero 1
PMCID: PMC1908272  PMID: 1786522

Abstract

1. In anaesthetized rats, an i.v. injection of endothelin-1 (0.25 nmol kg-1) evoked a rapidly appearing (maximal effect within 15 s) and short lasting (3 min) fall in blood pressure with tachyphylaxis occurring so that it was reduced by 50% by the last of 4 injections given 10 min apart. This property was also shared by endothelin-2, endothelin-3 and vasoactive intestinal contractor (VIC). 2. Cross tachyphylaxis between the isopeptides occurred. However, under the same experimental conditions the hypotensive effects of acetylcholine, adenosine, atrial natriuretic peptide (ANP) and substance P were reproducible and not modified in animals in which endothelin-1 no longer lowered blood pressure. Thus, the mechanism of the hypotensive action of endothelin peptides is different from that of acetylcholine, adenosine, ANP, and substance P. 3. In pithed rats, endothelin-1 (0.25 nmol kg-1) and its precursor human proendothelin (h-proendothelin) (0.5 nmol kg-1) induced pressor responses of a similar magnitude, which for h-proendothelin (up to 5.0 nmol kg-1) were not preceded by a hypotensive phase. The pressor effects of endothelin-1, like those of vasopressin, were reproducible upon repeated i.v. injections. 4. Rats given a 10 min infusion (0.1 nmol kg-1 min-1) of endothelin-1 showed no hypotensive response to an i.v. bolus injection of endothelin-1, whereas animals pretreated with an equipressor infusion of h-proendothelin did not develop tachyphylaxis to endothelin-1. 5. In pitched rats, endothelin-1, at a dose inducing the same maximal increase in blood pressure as h-proendothelin, was approximately 3 fold more potent as a mesenteric vasoconstrictor than h-proendothelin.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
77

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. D'Orléans-Juste P., Lidbury P. S., Warner T. D., Vane J. R. Intravascular big endothelin increases circulating levels of endothelin-1 and prostanoids in the rabbit. Biochem Pharmacol. 1990 May 1;39(9):R21–R22. doi: 10.1016/0006-2952(90)90419-l. [DOI] [PubMed] [Google Scholar]
  2. Fozard J. R., Part M. L. No major role for atrial natriuretic peptide in the vasodilator response to endothelin-1 in the spontaneously hypertensive rat. Eur J Pharmacol. 1990 May 3;180(1):153–159. doi: 10.1016/0014-2999(90)90603-4. [DOI] [PubMed] [Google Scholar]
  3. Fukuroda T., Noguchi K., Tsuchida S., Nishikibe M., Ikemoto F., Okada K., Yano M. Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem Biophys Res Commun. 1990 Oct 30;172(2):390–395. doi: 10.1016/0006-291x(90)90685-g. [DOI] [PubMed] [Google Scholar]
  4. Gardiner S. M., Compton A. M., Bennett T., Hartley C. J. Can pulsed Doppler technique measure changes in aortic blood flow in conscious rats? Am J Physiol. 1990 Aug;259(2 Pt 2):H448–H456. doi: 10.1152/ajpheart.1990.259.2.H448. [DOI] [PubMed] [Google Scholar]
  5. Gardiner S. M., Compton A. M., Bennett T., Palmer R. M., Moncada S. NG-monomethyl-L-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats. Eur J Pharmacol. 1989 Nov 21;171(2-3):237–240. doi: 10.1016/0014-2999(89)90113-1. [DOI] [PubMed] [Google Scholar]
  6. Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats. Br J Pharmacol. 1990 Jan;99(1):107–112. doi: 10.1111/j.1476-5381.1990.tb14662.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hioki Y., Okada K., Ito H., Matsuyama K., Yano M. Endothelin converting enzyme of bovine carotid artery smooth muscles. Biochem Biophys Res Commun. 1991 Jan 31;174(2):446–451. doi: 10.1016/0006-291x(91)91436-g. [DOI] [PubMed] [Google Scholar]
  8. Hirata Y., Yoshimi H., Takaichi S., Yanagisawa M., Masaki T. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett. 1988 Oct 24;239(1):13–17. doi: 10.1016/0014-5793(88)80536-2. [DOI] [PubMed] [Google Scholar]
  9. Hoffman A., Grossman E., Keiser H. R. Opposite effects of endothelin-1 and Big-endothelin-(1-39) on renal function in rats. Eur J Pharmacol. 1990 Jul 17;182(3):603–606. doi: 10.1016/0014-2999(90)90064-d. [DOI] [PubMed] [Google Scholar]
  10. Ikegawa R., Matsumura Y., Takaoka M., Morimoto S. Evidence for pepstatin-sensitive conversion of porcine big endothelin-1 to endothelin-1 by the endothelial cell extract. Biochem Biophys Res Commun. 1990 Mar 16;167(2):860–866. doi: 10.1016/0006-291x(90)92104-8. [DOI] [PubMed] [Google Scholar]
  11. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863–2867. doi: 10.1073/pnas.86.8.2863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kashiwabara T., Inagaki Y., Ohta H., Iwamatsu A., Nomizu M., Morita A., Nishikori K. Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo. FEBS Lett. 1989 Apr 10;247(1):73–76. doi: 10.1016/0014-5793(89)81243-8. [DOI] [PubMed] [Google Scholar]
  13. Le Monnier de Gouville A. C., Mondot S., Lippton H., Hyman A., Cavero I. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats. J Pharmacol Exp Ther. 1990 Jan;252(1):300–311. [PubMed] [Google Scholar]
  14. Matsumura Y., Hisaki K., Takaoka M., Morimoto S. Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1. Eur J Pharmacol. 1990 Aug 21;185(1):103–106. doi: 10.1016/0014-2999(90)90216-s. [DOI] [PubMed] [Google Scholar]
  15. Matsumura Y., Ikegawa R., Takaoka M., Morimoto S. Conversion of porcine big endothelin to endothelin by an extract from the porcine aortic endothelial cells. Biochem Biophys Res Commun. 1990 Feb 28;167(1):203–210. doi: 10.1016/0006-291x(90)91751-d. [DOI] [PubMed] [Google Scholar]
  16. Matsumura Y., Ikegawa R., Tsukahara Y., Takaoka M., Morimoto S. Conversion of big endothelin-1 to endothelin-1 by two types of metalloproteinases derived from porcine aortic endothelial cells. FEBS Lett. 1990 Oct 15;272(1-2):166–170. doi: 10.1016/0014-5793(90)80475-x. [DOI] [PubMed] [Google Scholar]
  17. McMahon E. G., Palomo M. A., Moore W. M., McDonald J. F., Stern M. K. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):703–707. doi: 10.1073/pnas.88.3.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nakajima K., Kubo S., Kumagaye S., Nishio H., Tsunemi M., Inui T., Kuroda H., Chino N., Watanabe T. X., Kimura T. Structure-activity relationship of endothelin: importance of charged groups. Biochem Biophys Res Commun. 1989 Aug 30;163(1):424–429. doi: 10.1016/0006-291x(89)92153-0. [DOI] [PubMed] [Google Scholar]
  19. Ohlstein E. H., Vickery L., Sauermelch C., Willette R. N. Vasodilation induced by endothelin: role of EDRF and prostanoids in rat hindquarters. Am J Physiol. 1990 Dec;259(6 Pt 2):H1835–H1841. doi: 10.1152/ajpheart.1990.259.6.H1835. [DOI] [PubMed] [Google Scholar]
  20. Ohnaka K., Takayanagi R., Yamauchi T., Okazaki H., Ohashi M., Umeda F., Nawata H. Identification and characterization of endothelin converting activity in cultured bovine endothelial cells. Biochem Biophys Res Commun. 1990 May 16;168(3):1128–1136. doi: 10.1016/0006-291x(90)91146-j. [DOI] [PubMed] [Google Scholar]
  21. Richer C., Lefevre-Borg F., Lechaire J., Gomeni C., Gomeni R., Giudicelli J. F., Cavero I. Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats. J Pharmacol Exp Ther. 1987 Mar;240(3):944–953. [PubMed] [Google Scholar]
  22. Robaut C., Mondon F., Bandet J., Ferre F., Cavero I. Regional distribution and pharmacological characterization of [125I]endothelin-1 binding sites in human fetal placental vessels. Placenta. 1991 Jan-Feb;12(1):55–67. doi: 10.1016/0143-4004(91)90510-m. [DOI] [PubMed] [Google Scholar]
  23. Saida K., Mitsui Y., Ishida N. A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family. Molecular cloning, expression, and biological activity. J Biol Chem. 1989 Sep 5;264(25):14613–14616. [PubMed] [Google Scholar]
  24. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES